Paper Details

  1. Home
  2. Paper Details

Pain Management Considerations in Patients Living with Both Pain Syndromes and Cardiovascular Diseases and Disorders.

Author: CarpenterAbigayle, LeppienEmily E, PaulingErin E, SchwierNicholas C, SmithEric, WisniewskiBrady

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This review examines the use of pharmacotherapy to treat pain syndromes in patients with cardiovascular disease (CVD). Several medications, including gabapentinoids, opioids, and non-steroidal anti-inflammatory drugs, have been used in patients with CVD. However, the literature on this topic is limited to retrospective studies, and there is a lack of well-designed, prospective, randomized trials. Prescribing pain management therapies for patients with CVD requires careful consideration of factors such as pain severity, type of pain, drug interactions, and the risk of adverse events.
Paper Details　
Original Abstract of the Article :
Concomitant pain syndromes and cardiovascular disease (CVD) and disorders are associated with significant morbidity, impaired quality of life, and neuropsychiatric disorders. There is an interplay between the mechanisms of pathophysiology of both CVD and pain syndromes. Patients with CVD (and/or dis...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/phar.2897

データ提供：米国国立医学図書館（NLM）

Navigating the Intersection of Pain and Cardiovascular Disease

The landscape of [pain syndromes and cardiovascular diseases (CVD)] is a complex and often challenging terrain, where the two conditions can interact in intricate ways. This study, like a seasoned physician navigating a maze of interconnected pathways, explores the considerations for [pain management] in patients living with both [pain syndromes and CVD]. Researchers reviewed the literature and analyzed clinical expertise to identify [pharmacotherapeutic approaches] that can effectively manage both conditions while minimizing the risk of [adverse events (AEs)].

A Delicate Balancing Act

The study highlights the importance of a [personalized approach] to [pain management] in patients with both [pain syndromes and CVD]. The findings emphasize the need for careful consideration of [drug-drug/disease interactions] and the potential risks associated with various [pharmacotherapies]. The study provides a valuable framework for healthcare professionals to navigate this complex area.

A Journey of Careful Consideration

This study serves as a reminder that [pain management] in patients with [CVD] requires a delicate balancing act. Healthcare professionals must carefully consider the potential benefits and risks of various treatments, ensuring that they effectively address [pain] while minimizing the risk of [cardiovascular complications]. Navigating this complex landscape requires a thorough understanding of the interplay between [pain syndromes and CVD].

Dr. Camel's Conclusion

This study provides a valuable roadmap for managing pain in patients with cardiovascular diseases. It underscores the importance of careful drug selection, considering potential interactions and risks. By adopting a personalized approach and staying vigilant, healthcare professionals can help these patients achieve adequate pain control while managing their cardiovascular health.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-12-04
Further Info :

Pubmed ID

38049207

DOI: Digital Object Identifier

10.1002/phar.2897

Related Literature

Article Analysis
・Side Effects of dronabinol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.